| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 859,300 | 962,200 | 2,137,800 | 1,778,500 | | Cost of Revenue | 527,800 | 591,600 | 1,380,100 | 1,171,100 | | | Gross Profit | 331,500 | 370,600 | 757,700 | 607,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 287,100 | 290,500 | 285,800 | 317,600 | | Non Recurring |
-
|
-
| 47,300 | (47,300) | | Others | 52,100 | 51,300 | 49,800 | 47,700 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,700) | 28,800 | 374,800 | 289,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 200 | (200) | | Earnings Before Interest And Taxes | (6,900) | 28,800 | 374,200 | 289,200 | | Interest Expense | 34,400 | 34,600 | 35,000 | 37,100 | | Income Before Tax | (41,300) | (5,800) | 339,200 | 252,100 | | Income Tax Expense | (12,900) | 6,400 | 97,400 | 68,200 | | Minority Interest | 20,500 | 8,600 | (83,600) | (69,000) | | | | Net Income From Continuing Ops | (11,000) | (3,600) | 158,200 | 114,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (11,000) | (3,600) | 158,200 | 114,900 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,000) | ($3,600) | $158,200 | $114,900 |
|
0.26% Nasdaq 0.00%
Income Statement
